Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different types of sweet corn and how they are processed can affect how our bodies digest them and respond in terms of blood sugar levels. The main goal is to find out the glycemic index, which is a measure of how quickly foods raise blood sugar after eating. Additionally, the study will also explore how eating sweet corn affects feelings of hunger and fullness.
To be eligible for this trial, participants should be between the ages of 65 and 75, be able to read and understand English, and be willing to eat specific amounts of glucose and sweet corn over several mornings. Participants will also need to provide small blood samples using a fingerstick, which is a quick and simple way to check blood sugar levels. However, individuals with certain health conditions that affect blood sugar, such as diabetes or metabolic syndrome, or those who are pregnant, cannot take part in this study. If you join, you can expect to help researchers learn more about sweet corn and its effects on our health!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Able to provide written consent in English
- • Willing to consume 50 g of glucose in less than 15 minutes (2 mornings)
- • Willing to consume around 250 to 350 g of sweet corn in 10 to 15 minutes (3 mornings)
- • Willing to provide 7 capillary blood samples by fingerstick (by fine lancet) during each 2-hour session
- Exclusion Criteria:
- • Metabolic disease or condition affecting blood glucose, such as diabetes type 1 and 2, metabolic syndrome, or polycystic ovary syndrome
- • Baseline fasting blood glucose \> 100 mg/dL
- • Currently pregnant
About University Of Florida
The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gainesville, Florida, United States
Gainesville, Florida, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported